Semaglutide is the FDA-approved active ingredient used in Wegovy^® and Ozempic^® that has helped thousands of people lose and maintain weight loss when combined with a healthy diet and regular exercise.

Semaglutide drastically reduces hunger, diminishing your desire for food, while also balancing your blood sugar levels and vanquishing your carbohydrate cravings.

Losing weight and adopting new dietary habits can be an intimidating task, but the Food and Drug Administration’s (FDA) latest prescription medication, Semaglutide, can help make the process easier and more successful. This drug works by replicating the action of Glucagon-like Peptide-1 (GLP-1), an important factor in insulin production, sugar balance, and metabolism.

Tirzepatide is the FDA-approved active ingredient used in Mounjaro^®. Recently approved for weight loss, Tirzepatide is a single molecule that activates the body’s receptors for GIP and GLP-1, which are natural incretin hormones. Both GIP and GLP-1 receptors are found in areas of the human brain important for appetite regulation. In clinical trails, Tirzepatide achieved up to 30% body weight loss for patients when combined with a healthy diet and regular exercise.

Tirzepatide drastically reduces hunger, diminishing your desire for food, while also balancing your blood sugar levels and vanquishing your carbohydrate cravings.

Tirzepatide works to decrease blood sugar levels by increasing insulin production and also lowering the amount of sugar the liver makes. It also slows the rate food passes through your body which makes you feel full longer.